AeRang Kim
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Early Phase Study Evaluating MEK and MDM2 Inhibition in Patients With NF1 and MPNST (NCT06735820) | AeRang Kim | 2026-06-01 |
Track AeRang Kim automatically
Every clearance here is in the API, with alerts when new ones post.